EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Strategy for Developing a Stable CHO Cell Line that Produces Large Titers of Trastuzumab Antibody

Hafsa Boulenouar, Nadia Bouchoutrouch, Youssef Amar, Moulay El Abbes Faouzi, Yahia Cherrah, Hassan Sefrioui, Hassan Ait Benhassou

Frontiers in Bioscience-Elite · 2023

DOI: 10.31083/j.fbe1504024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Elite, 2023. Verfasst von Hafsa Boulenouar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology & Toxicology, Faculty of Medicine & Pharmacy, University Mohammed V in rabat, 10170 Rabat, Morocco. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moroccan Foundation for Advanced Sciences, Innovation and Research (MAScIR), Moroccan MESRSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trastuzumab (Herceptin®) is currently the main treatment option for breast cancer patients that overexpress the human epidermal growth factor receptor 2 (HER2). This antibody binds specifically to HER2, blocks cancer cell growth, and promotes effective cell death. In the present study, we sought to develop a robust and efficient process for the development of a stable Chinese hamster ovary (CHO) cell line with high trastuzumab expression and production.

Methods

We adapted a process that combines transposon system-based vector construction, suspension cell culture, and a high selection process. The latter, involved enhanced green fluorescent protein (eGFP) expression, fluorescence-activated cell sorting (FACS), and semi-solid methylcellulose media.

Results

The construction of trastuzumab as a humanized monoclonal antibody was achieved by subcloning the synthesized light and heavy chain sequences into a suitable piggyBac expression vector. The optimized piggyBac vector used for the expression of trastuzumab in CHO cells resulted in the production of trastuzumab and reached 4.24 g/L in the T1A7 clone after a 7-day batch culture. The T1A7 clone was selected after screening over 1500 clones.

Conclusions

The current simple workflow ensures strict monoclonality and relatively high production of trastuzumab. This workflow could potentially be implemented in Research and Development (R&D) laboratories, including in developing countries for the production of recombinant monoclonal antibodies in a cost-effective manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalBreast NeoplasmsCricetinaeAnimalsHumansFemaleTrastuzumabCricetulusCHO CellsErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

CHOFACS/Methylcellulose media (MCM)PiggyBacbatch-modetrastuzumab

Substanzen

TrastuzumabAntibodies, MonoclonalErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Laboratory of Pharmacology & Toxicology, Faculty of Medicine & Pharmacy, University Mohammed V in rabat, 10170 Rabat, Morocco.
  • Prevention & Therapeutics Center, Moroccan Foundation for Advanced Science Innovation & Research (MAScIR), 10112 Rabat, Morocco.
  • Faculty of Pharmacy, Abulcasis International University of Health Sciences, 10112 Rabat, Morocco.
  • Moroccan Foundation for Advanced Science Innovation & Research (MAScIR), 10112 Rabat, Morocco.

Förderung

  • Moroccan Foundation for Advanced Sciences, Innovation and Research (MAScIR)
  • Moroccan MESRSF

Zitieren

APA

Boulenouar, H., Bouchoutrouch, N., Amar, Y., Faouzi, M. E. A., Cherrah, Y., Sefrioui, H., & Benhassou, H. A. (2023). Strategy for Developing a Stable CHO Cell Line that Produces Large Titers of Trastuzumab Antibody. Frontiers in Bioscience-Elite. https://doi.org/10.31083/j.fbe1504024

Vancouver

Boulenouar H, Bouchoutrouch N, Amar Y, Faouzi MEA, Cherrah Y, Sefrioui H, et al. Strategy for Developing a Stable CHO Cell Line that Produces Large Titers of Trastuzumab Antibody. Frontiers in Bioscience-Elite. 2023. doi:10.31083/j.fbe1504024

BibTeX
@article{Boulenouar2023,
  author = {Boulenouar, Hafsa and Bouchoutrouch, Nadia and Amar, Youssef and Faouzi, Moulay El Abbes and Cherrah, Yahia and Sefrioui, Hassan and Benhassou, Hassan Ait},
  title = {Strategy for Developing a Stable CHO Cell Line that Produces Large Titers of Trastuzumab Antibody},
  journal = {Frontiers in Bioscience-Elite},
  year = {2023},
  doi = {10.31083/j.fbe1504024}
}
Kostenlos starten →